Management of breast cancer with hormones and drugs

M. E. Lippman

Management of breast cancer with hormones and drugs

M. E. Lippman

Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Because more than one third of patients with early breast cancer die of metastatic disease after primary local-regional treatment, systemic adjuvant therapy is often needed. Adjuvant combination chemotherapy is now standard in premenopausal women with positive axillary nodes. For postmenopausal women with positive nodes and steroid hormone receptors, endocrine therapy may be effective.

Original language	English (US)
Pages (from-to)	119-131
Number of pages	13
Journal	Hospital Practice
Volume	21
Issue number	5
State	Published - Jan 1 1986

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{2f6b7225a58344a4861e4bff1fa0e102,

title = "Management of breast cancer with hormones and drugs",

abstract = "Because more than one third of patients with early breast cancer die of metastatic disease after primary local-regional treatment, systemic adjuvant therapy is often needed. Adjuvant combination chemotherapy is now standard in premenopausal women with positive axillary nodes. For postmenopausal women with positive nodes and steroid hormone receptors, endocrine therapy may be effective.",

author = "Lippman, {M. E.}",

year = "1986",

month = jan,

day = "1",

language = "English (US)",

volume = "21",

pages = "119--131",

journal = "Hospital practice (1995)",

issn = "2154-8331",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Management of breast cancer with hormones and drugs

AU - Lippman, M. E.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Because more than one third of patients with early breast cancer die of metastatic disease after primary local-regional treatment, systemic adjuvant therapy is often needed. Adjuvant combination chemotherapy is now standard in premenopausal women with positive axillary nodes. For postmenopausal women with positive nodes and steroid hormone receptors, endocrine therapy may be effective.

AB - Because more than one third of patients with early breast cancer die of metastatic disease after primary local-regional treatment, systemic adjuvant therapy is often needed. Adjuvant combination chemotherapy is now standard in premenopausal women with positive axillary nodes. For postmenopausal women with positive nodes and steroid hormone receptors, endocrine therapy may be effective.

UR - http://www.scopus.com/inward/record.url?scp=0022470660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022470660&partnerID=8YFLogxK

M3 - Article

C2 - 3009506

AN - SCOPUS:0022470660

VL - 21

SP - 119

EP - 131

JO - Hospital practice (1995)

JF - Hospital practice (1995)

SN - 2154-8331

IS - 5

ER -

Management of breast cancer with hormones and drugs

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this